Cargando…
Systemic therapies in hepatocellular carcinoma: Existing and emerging biomarkers for treatment response
Hepatocellular carcinoma (HCC) is the fifth most common malignancy and the third most common cause of cancer-related death worldwide. Due to asymptomatic patients in the early stage, most patients are diagnosed at an advanced stage and lose the opportunity for radical resection. In addition, for pat...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723250/ https://www.ncbi.nlm.nih.gov/pubmed/36483039 http://dx.doi.org/10.3389/fonc.2022.1015527 |